ETON PHARMACEUTICALS INC (ETON) Institutional Ownership and Insiders Activity
ETON PHARMACEUTICALS INC (ETON) is widely held by institutional investors, with 161 firms reporting positions valued at approximately $720.01M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Opaleye Management Inc. is the largest disclosed holder, reporting approximately $103.53M in ETON holdings in its latest filing.
Recent insider activity includes 12 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
161
Total Reported Value
$720.01M
Largest Holder
Opaleye Management Inc.
Largest Position
$103.53M
Insider Transactions (90d)
12
Latest Filing Quarter
Q2 2026
New Institutional Positions
55
Funds Exiting Positions
10
Top Institutional Owners
View allInvestorReported Balance
- Opaleye Management Inc.$103.53M
- Ecor1 Capital, Llc$78.62M
- Blackrock, Inc.$68.63M
- Nantahala Capital Management, Llc$42.57M
- Vanguard Capital Management Llc$35.35M
ETON News
All news- Nantahala Capital Management Q3 2026 Investment Activity
Aug 20, 2026 · valut.ai
Related ETON Institutional Insights:
- ETON 13F Institutional Holders
- ETON Top Institutional Shareholders
- ETON Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ETON Insider Trading & SEC Form 4 Activity
- ETON Articles
- Top Institutional Investor Stock Rankings